Debt-to-equity of Tango Therapeutics, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tango Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Tango Therapeutics, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 39%, a 29% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Tango Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 39% -16% -29% 31 Dec 2025
Q3 2025 57% +2% +3.6% 30 Sep 2025
Q2 2025 62% +6.4% +11% 30 Jun 2025
Q1 2025 57% -3.4% -5.6% 31 Mar 2025
Q4 2024 55% -12% -17% 31 Dec 2024
Q3 2024 55% -15% -22% 30 Sep 2024
Q2 2024 55% -20% -26% 30 Jun 2024
Q1 2024 60% -6.7% -9.9% 31 Mar 2024
Q4 2023 66% +6.9% +12% 31 Dec 2023
Q3 2023 71% +18% +35% 30 Sep 2023
Q2 2023 75% +28% +60% 30 Jun 2023
Q1 2023 67% +23% +53% 31 Mar 2023
Q4 2022 59% +19% +47% 31 Dec 2022
Q3 2022 52% -15% -22% 30 Sep 2022
Q2 2022 47% -48% -50% 30 Jun 2022
Q1 2022 44% 31 Mar 2022
Q4 2021 40% 31 Dec 2021
Q3 2021 67% 30 Sep 2021
Q2 2021 94% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.